|Awarded On||February 18, 2015|
|Title||Multi-component interventions for patients and providers to increase HPV vaccination in a network of pediatric clinics in Houston, TX|
|Award Mechanism||Individual Investigator Research Awards for Prevention and Early Detection|
|Institution/Organization||The University of Texas Health Science Center at Houston|
|Principal Investigator/Program Director||Sally Vernon|
|Cancer Sites||Cervix Uteri, Head and Neck, Penis, Vagina, Vulva|
HPV is a major cause of morbidity and mortality that can be reduced or prevented through HPV vaccination. Despite evidence of safety and efficacy, and endorsement by professional organizations, HPV vaccination rates are suboptimal. Provider and healthcare system factors are important determinants of parents’ decisions to vaccinate their child against HPV. Although the single most important determinant is receiving a recommendation from a healthcare provider, only 40% of physicians report routinely recommending HPV vaccination for 11-12 year old girls and only 33% report recommending it for 11-12 year old boys. The primary goal of our project is to increase initiation (at least 1 dose) of HP...